title: Improved strategies and new treatment options for allergic rhinitis.
abstract: Primary principles relevant to the clinical management of allergic rhinitis include (1) avoidance of allergens and triggering factors, (2) use of appropriate pharmacotherapy, (3) evaluation regarding need for and appropriate use of immunotherapy, and (4) patient education and follow-up. Currently available pharmacotherapeutic options include oral and topical (intranasal) decongestants and corticosteroids, mast cell stabilizers, intranasal anticholinergics, and antihistamines. Future therapeutic options include leukotriene modifiers and anti-IgE antibodies.
authors.affiliation: University of Health Sciences-College of Osteopathic Medicine in Kansas City, MO, USA. swillsie@uhs.edu
authors.forename: Sandra K
authors.initials: SK
authors.lastname: Willsie
mesh_terms: D000281:Administration, Intranasal; D001507:Beclomethasone / Q000627:therapeutic use; D004205:Cromolyn Sodium / Q000627:therapeutic use; D006634:Histamine H1 Antagonists / Q000145:classification / Q000627:therapeutic use; D006801:Humans; D007073:Immunoglobulin E / Q000276:immunology; D007167:Immunotherapy; D014663:Nasal Decongestants / Q000627:therapeutic use*; D010109:Oxymetazoline / Q000627:therapeutic use*; D012221:Rhinitis, Allergic, Perennial / Q000188:drug therapy; D006255:Rhinitis, Allergic, Seasonal / Q000188:drug therapy* / Q000503:physiopathology
chemical_list: D006634:Histamine H1 Antagonists; D014663:Nasal Decongestants; D007073:Immunoglobulin E; D010109:Oxymetazoline; D001507:Beclomethasone; D004205:Cromolyn Sodium